2022 NOSCM | Management of Side Effects of Soome Common Targeted Therapies (ALK/BTK/IDH 1/2 Inbibitors

2022 NOSCM | Management of Side Effects of Soome Common Targeted Therapies (ALK/BTK/IDH 1/2 Inbibitors

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Paola Izquierdo, ARNP, BSN, FNP-BC

Date of Release

May 14th, 2025